Do Residential Aged Care Facilities benefit from oseltamivir treatment of cases plus prophylaxis of contacts, versus oseltamivir treatment of cases alone, with respect to reducing influenza outbreak frequency, duration and complications?

Trial Profile

Do Residential Aged Care Facilities benefit from oseltamivir treatment of cases plus prophylaxis of contacts, versus oseltamivir treatment of cases alone, with respect to reducing influenza outbreak frequency, duration and complications?

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 23 Jun 2016

At a glance

  • Drugs Oseltamivir (Primary)
  • Indications Influenza virus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top